SolveBio is a contextual knowledge hub focused on enabling pharma, biotech, and diagnostic organizations to effectively connect and use external and internal genomic information. SolveBio extracts, evaluates, and unifies complex, disparate biomedical data for life science enterprises. The company works with diagnostic and R&D labs to massively scale their precision medicine offering. Screening, Rare Disease, and Oncology genetics requires accurate and fast assessment of variants. The SolveBio Genome Intelligence Service combines SolveBio’s proprietary data harmonization engine with a global network of trained genomics experts to deliver high-throughput, transparent, and reproducible DNA variant interpretation. SolveBio curation is scalable and available on-demand, allowing companies and labs to scale variant assessment as their test volume grows.
Company Growth (employees)
New York, US
Size (employees)
11 (est)+10%
SolveBio was founded in 2013 and is headquartered in New York, US

Key People/Management at SolveBio

Mark Kaganovich

Mark Kaganovich

David Caplan

David Caplan


SolveBio Office Locations

SolveBio has an office in New York
New York, US (HQ)
194 Mercer Street 627 Broadway
Show all (1)

SolveBio Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$2 m

Time since last funding

over 2 years


SolveBio's Web-traffic and Trends

SolveBio Online and Social Media Presence

SolveBio Company Life and Culture

You may also be interested in